Epidemiological Study to Assess the Prevalence of Lung Cancer in patients with smoking-associated atherosclerotic cardiovascular diseases: PREVALUNG study protocol - Institut Gustave Roussy Access content directly
Journal Articles BMJ Open Year : 2022

Epidemiological Study to Assess the Prevalence of Lung Cancer in patients with smoking-associated atherosclerotic cardiovascular diseases: PREVALUNG study protocol

Caroline Caramella
  • Function : Author
  • PersonId : 1091231
Marc Zins
Elie Fadel
  • Function : Author
  • PersonId : 852957
Olaf Mercier

Abstract

Eligibility criteria definition for a lung cancer screening (LCS) is an unmet need. We hypothesised that patients with a history of atheromatous cardiovascular disease (ACVD) associated with tobacco consumption are at risk of lung cancer (LC). The main objective is to assess LC prevalence among patients with ACVD and history of tobacco consumption by using low-dose chest CT scan. Secondary objectives include the evaluation LCS in this population and the constitution of a biological biobank to stratify risk of LC.
Fichier principal
Vignette du fichier
e067191.full.pdf (261.18 Ko) Télécharger le fichier
Origin : Files produced by the author(s)

Dates and versions

hal-03926501 , version 1 (16-11-2023)

Identifiers

Cite

David Boulate, Marine Fidelle, Caroline Caramella, Justin Issard, Olivier Planche, et al.. Epidemiological Study to Assess the Prevalence of Lung Cancer in patients with smoking-associated atherosclerotic cardiovascular diseases: PREVALUNG study protocol. BMJ Open, 2022, 12 (12), ⟨10.1136/bmjopen-2022-067191⟩. ⟨hal-03926501⟩
78 View
13 Download

Altmetric

Share

Gmail Facebook X LinkedIn More